GenMark Q4, FY 2012 Revenues Jump Sharply | GenomeWeb

NEW YORK (GenomeWeb News) – GenMark Diagnostics reported after the close of the market Tuesday that its fourth-quarter revenues increased 364 percent year over year, driven by reagent sales from greater system placements.

The Carlsbad, Calif.-based molecular diagnostics firm had total revenues of $9.4 million for the three months ended Dec. 31, compared to $2 million for the fourth quarter of 2011. Its reagent sales were up more than 400 percent to $9.1 million from $1.8 million, while its instrument and other revenues climbed 39 percent to $312,000 from $224,000.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: personal genome approach to RNA-seq read alignment, hematopoietic Systems Biology Repository, and more.

A man is using DNA evidence to argue that he is the rightful heir to the baronetcy of Stichill, the Guardian reports.

As part of an effort to get a diverse group of people to donate their DNA for research, some blood donors in the San Diego area will get their genomes sequenced, according to KPBS.

The comment period on the Department of Health and Human Services' proposal to alter the Common Rule has been extended.